-
公开(公告)号：KR1020080034575A
公开(公告)日：2008-04-22
申请号：KR1020060100703
申请日：2006-10-17
Applicant: (주)아모레퍼시픽
IPC: A61K31/047 , A61K31/13
CPC classification number: A61K31/047
Abstract: A method for inhibiting the expression of CCL27/CTACK(Cutaneous T-cell-attracting chemokine) is provided to regulate SPC(sphingosylphosphorylcholine) inducing expression of CCL27/CTACK, so that the method is useful for prevention and treatment of diseases associated with overexpression of CCL27/CTACK including atopic dermatitis, psoriasis and inflammatory skin disease. The expression of CCL27/CTACK is inhibited by administering an effective amount of sphingosylphosphorylcholine regulator capable of inhibiting activity of SPC or competing with the mechanism of SPC inducing overexpression of CCL27/CTACK to a mammal requiring the expression reduction of CCL27/CTACK. A method for screening the SPC regulator comprises the steps of: (1) treating a testing cell such as keratinocyte with 2-10 muM of SPC or its derivatives to induce overexpression of CCL27/CTACK; and (2) treating the overexpression of CCL27/CTACK-induced cell with a candidate material and measuring the expression inhibition of CCL27/CTACK. Further, the mammal has an atopic dermatitis or psoriasis.
Abstract translation: 提供抑制CCL27 / CTACK（皮肤T细胞吸引趋化因子）表达的方法，以调节诱导CCL27 / CTACK表达的SPC（鞘氨醇磷酰胆碱），从而该方法可用于预防和治疗与过表达相关的疾病 CCL27 / CTACK包括特应性皮炎，牛皮癣和炎性皮肤病。 通过施用有效量的能够抑制SPC活性或与诱导CCL27 / CTACK过表达的SPC的机制竞争需要CCL27 / CTACK表达降低的哺乳动物，CCL27 / CTACK的表达被抑制。 用于筛选SPC调节剂的方法包括以下步骤：（1）用2-10μM的SPC或其衍生物处理测试细胞如角质细胞，以诱导CCL27 / CTACK的过度表达; 和（2）用候选物质治疗CCL27 / CTACK诱导的细胞的过度表达，并测量CCL27 / CTACK的表达抑制。 此外，哺乳动物具有特应性皮炎或牛皮癣。
-
公开(公告)号：KR1020070107961A
公开(公告)日：2007-11-08
申请号：KR1020060040588
申请日：2006-05-04
Applicant: (주)아모레퍼시픽
IPC: A61K36/9068 , A61K36/754
CPC classification number: A61K36/00 , A61K8/97 , A61K9/00 , A61K36/754 , A61K36/9062 , A61K36/9068 , A61K2236/33 , A61Q19/00 , A61Q19/005 , Y10S514/857
Abstract: A composition comprising extracts of crude drugs is provided to suppress and relieve itching caused by inflammatory and atopic dermatitis without side effects such as toxicity and skin irritation. A composition for suppressing and relieving itching comprises 0.1-10 wt.% of the extracts of Zingiber officinale Rosc., Evodia officinalis and Alpinia katsumadai Hayata which are prepared by extracting them with water, C1-C4 lower alcohol or a mixed solvent thereof. The daily dosage of crude drug extracts is 0.001-100 mg/kg, preferably 0.1-30 mg/kg and the composition is a pharmaceutical composition having a formulation selected from ointment, plaster, lotion and liniment, or a cosmetic composition having a formulation selected from skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisture lotion, nutrition lotion, massage cream, nutrition cream, moisture cream, hand cream, foundation, essence, nutrition essence, pack, soap, cleansing foam, cleansing lotion, cleansing cream, body lotion and body cleanser.
Abstract translation: 提供包含生药提取物的组合物以抑制和缓解由炎性和特应性皮炎引起的瘙痒，而没有副作用，例如毒性和皮肤刺激。 用于抑制和缓解瘙痒的组合物包括通过用水，C1-C4低级醇或其混合溶剂提取它们制备的姜黄提取物的0.1-10重量％的提取物。 生药提取物的日剂量为0.001-100mg / kg，优选0.1-30mg / kg，并且组合物是具有选自软膏，石膏，洗剂和搽剂的制剂的药物组合物或具有选择的制剂的化妆品组合物 从皮肤洗剂，皮肤柔肤剂，皮肤调色剂，收敛剂，乳液，乳液，滋润乳液，营养乳液，按摩霜，营养霜，保湿霜，护手霜，粉底，精华，营养精华，包装，肥皂，清洁泡沫，清洁 洗剂，清洁霜，身体乳液和身体清洁剂。
-
公开(公告)号：KR100682729B1
公开(公告)日：2007-02-15
申请号：KR1020050051196
申请日：2005-06-15
Applicant: (주)아모레퍼시픽
IPC: A61K9/70
CPC classification number: A61K9/7061 , A61K47/18
Abstract: 본 발명은 소수성 고분자 점착제 매트릭스 층을 포함하는 경피흡수제제 및 그의 제조 방법에 관한 것이다. 본 발명의 제제는 약효성분을 포함하는 액적이 고분자 매트릭스 내에 고루 분산되어 있어서 높은 피부흡수를 나타낼 뿐만 아니라, 제조과정이 단순하면서도 약효성분의 용해도에 따른 제한 없이 약효성분을 고농도로 함유할 수 있어서 여러 가지 약물에 적용이 가능하다.
매트릭스, 경피흡수제제, 휘발성 유기용매, 극성 비양자성 유기용매-
Patent Agency Ranking
公开(公告)号：KR1020060060371A
公开(公告)日：2006-06-05
申请号：KR1020040099426
申请日：2004-11-30
Applicant: (주)아모레퍼시픽
CPC classification number: A61K9/2886
Abstract: 본 발명은 선택적 세로토닌 재흡수 억제제의 연장방출 제제 및 그 제조방법에 관한 것으로, 본 발명에 따라 침식성 수용성 고분자, 형태유지보완성 하이드로겔 및 약제학적 첨가제로 이루어진 단일층 매트릭스에 선택적 세로토닌 재흡수 억제제가 유효량 담지된 것을 특징으로 하는 연장방출 제제는, 침식성 수용성 고분자 및 하이드로겔로 구성된 단일층 매트릭스의 침식에 의해 약물이 흡수부위에서 일정속도로 방출 및 흡수되어 혈중 약물농도의 급격한 상승을 방지하고, 국소자극을 최소화하여 부작용의 발생을 둔화시키며, 위장관 운동 등의 외부 물리적 환경에 의한 영향을 최소화하므로 안정화된 0차 방출을 제공하는 경구용 고형 제제로서 유용하게 활용될 수 있다.
-
公开(公告)号：KR100824218B1
公开(公告)日：2008-04-25
申请号：KR1020060128318
申请日：2006-12-15
Applicant: 재단법인서울대학교산학협력재단
Abstract: A method for producing a cloned wolf is provided to contribute to preserve a rare and endangered species wolf and develop veterinary medicine, anthropology and medicine study fields. A method for preparing a nuclear transplant embryo of wolf comprises the steps of: (a) removing a nucleus from ovum of a canine animal such as dog, wolf, fox, jackal, coyote, dhole, and raccoon dog to prepare a denucleated ovum; (b) isolating a somatic cell from a tissue of the wolf to prepare a donor nucleus cell; (c) micro-injecting the donor nucleus cell into the denucleated ovum and electrofusing it; and (d) activating the fused ovum. A nuclear transplant embryo prepared by the method is deposited as a deposition no. KCTC 10903BP. A method for producing a cloned wolf comprises a step of transplanting the nuclear transplant embryo into an oviduct of a canine animal surrogate mother. Further, the electrofusing step is performed at a voltage of 3.6 to 4.1 kv/cm, for 10 to 30 mus, 1 to 3 times.
Abstract translation: 提供了克隆狼的生产方法，有助于保护珍稀濒危物种狼，开发兽药，人类学和医学研究领域。 制备狼的核移植胚胎的方法包括以下步骤：（a）从狗，狼，狐狸，豺狼，土拨鼠，hole和浣熊犬等动物的卵中除去核，以制备脱核卵; （b）从狼的组织中分离体细胞以制备供体核细胞; （c）将供体核细胞微注射到去核的卵中并将其电铸; 和（d）激活融合的卵子。 通过该方法制备的核移植胚胎被沉积为沉积物。 KCTC 10903BP。 克隆的狼的制备方法包括将核移植胚胎移植到犬动物替代母亲的输卵管中的步骤。 此外，电熔步骤在3.6至4.1kv / cm的电压下进行10至30次，1至3次。
-
公开(公告)号：KR100829426B1
公开(公告)日：2008-05-15
申请号：KR1020070005350
申请日：2007-01-17
Applicant: 재단법인서울대학교산학협력재단
IPC: A01K67/00 , A01K67/027 , C12N5/07
CPC classification number: C12N15/873 , A01K67/027 , A01K2227/00 , A61D19/04
Abstract: A method for producing a cloned dog is provided to obtain a method for producing a cloned dog that produces an embryo in an optimal fusion condition. A preparing method of an embryo of a dog includes the steps of: preparing an enucleated ovum of an animal except for a human being; preparing a donor somatic cell; injecting minutely and electrically fusing the donor somatic cell; and activating the fused ovum. The electric fusion is conducted in a condition that the voltage is 3.8-5.0kV/cm. The electric fusion is conducted twice for 15-25mus by using a needle type electrode. The embryo is transplanted in an oviduct of a surrogate mother.
Abstract translation: 提供了克隆狗的制备方法，以获得在最佳融合条件下产生胚胎的克隆狗的制备方法。 狗的胚胎的制备方法包括以下步骤：制备除人之外的动物的去核卵; 准备供体体细胞; 注射和电熔融供体体细胞; 并激活融合的卵子。 电压在3.8-5.0kV / cm的电压下进行。 通过使用针式电极将电融合进行两次15-25m。 将胚胎移植到代孕母亲的输卵管中。
-
公开(公告)号：KR1020070013432A
公开(公告)日：2007-01-31
申请号：KR1020050067736
申请日：2005-07-26
Applicant: 재단법인서울대학교산학협력재단
IPC: C12N5/16
CPC classification number: C12N15/877
Abstract: Cloned Canidae and a method for producing thereof are provided to clone the Canidae by somatic cell nuclear transfer, so that the method is useful for propagation of excellent Canidae species and preservation of rare and endangered Canidae species. The method for producing the cloned Canidae comprises the steps of: (a) removing a nucleus from the matured oocyte of Canidae; (b) separating the somatic cell from the tissue of Canidae so as to prepare a nucleus donor cell; (c) micro-injecting the nucleus donor cell into the denucleated oocyte, and electronically fusing the oocyte by applying voltage of 3.0-3.5 kv/cm to the oocyte; and (d) activating the electrofused oocyte by treating the electrofused oocyte with calcium ionophore and DMAP(6-dimethylaminopurine), wherein the somatic cell is fibroblast or cumulus cell; the Canidae is dog, wolf, fox, jackal, coyote, Korean wolf or raccoon. The cloned Canidae oocyte is deposited under KCTC 10831BP.
Abstract translation: 提供了克隆犬科及其生产方法，通过体细胞核转移克隆犬科，使该方法对于优良犬科的种繁殖和保存珍稀濒危的犬科物种有用。 产生克隆的犬科的方法包括以下步骤：（a）从犬科的成熟卵母细胞中除去核; （b）从犬科的组织分离体细胞以制备核供体细胞; （c）将核供体细胞微注射到去核卵母细胞中，并通过向卵母细胞施加3.0-3.5kv / cm的电压来电子融合卵母细胞; 和（d）通过用钙离子载体和DMAP（6-二甲氨基嘌呤）处理电熔卵母细胞来激活电熔卵母细胞，其中体细胞是成纤维细胞或卵丘细胞; 犬科是狗，狼，狐狸，豺狼，土狼，韩国狼或浣熊。 克隆的犬科卵母细胞保藏在KCTC 10831BP下。
-
公开(公告)号：KR100733012B1
公开(公告)日：2007-06-28
申请号：KR1020050067736
申请日：2005-07-26
Applicant: 재단법인서울대학교산학협력재단
IPC: C12N5/16
CPC classification number: C12N15/877
Abstract: 본 발명은 복제된 개과 동물 및 이의 생산방법에 관한 것이다. 보다 구체적으로 본 발명은 개과 동물의 성숙 난자로부터 핵을 제거하여 탈핵 난자를 제조한 다음 개과 동물의 체세포를 공여 핵 세포로 이용하여 상기 탈핵 난자에 최적화된 조건으로 핵 이식을 수행하여 핵 이식란을 제조하고, 이를 대리모의 난관에 이식하는 것을 특징으로 하는 복제된 개과 동물의 생산방법 및 상기 방법에 의해 생산된 복제된 개과 동물에 관한 것이다.
본 발명에 따른 방법은 복제된 개과 동물을 생산하는 효과가 있으며 이는 우량 개과 동물의 번식, 희귀· 멸종 위기의 개과 동물의 보존, 이종이식, 질환 모델동물 등 수의학, 인류학 및 의학연구 분야의 발달에 기여할 수 있다.
복제, 개과 동물, 핵 이식, 체내 성숙 난자
-
-
-
-
-
-
-
Search Results
68
records
(took 0.027 seconds)
